Skip to main content
VCbacked
Log inGet Started

Imbria Pharmaceuticals

Boston, United States

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

$59.2M raised
Apr 2025
Series B
BiotechnologyHealth CareLife SciencePharmaceutical

Top Investors

RA Capital ManagementSV Health InvestorsCatalio Capital ManagementCytokineticsDeep Track Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Imbria Pharmaceuticals

How much funding has Imbria Pharmaceuticals raised?
Imbria Pharmaceuticals has raised $59.2M in total funding. The most recent round was Series B. The last funding was announced in April 2025.
Who are Imbria Pharmaceuticals's investors?
Imbria Pharmaceuticals's investors include RA Capital Management, SV Health Investors, Catalio Capital Management, Cytokinetics, Deep Track Capital.
Where is Imbria Pharmaceuticals headquartered?
Imbria Pharmaceuticals is headquartered in Boston, United States.
What does Imbria Pharmaceuticals do?
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
What stage is Imbria Pharmaceuticals at?
Imbria Pharmaceuticals is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Imbria Pharmaceuticals — Funding & Investors." VCBacked, April 10, 2025, https://www.vcbacked.co/company/imbria-pharmaceuticals. Accessed June 3, 2026.
APA
VCBacked. (2025). Imbria Pharmaceuticals — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/imbria-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Imbria Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/imbria-pharmaceuticals |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong